Full Fed. Circ. Asked To Undo Forum Selection Clause Ruling
Sarepta Therapeutics has urged the full Federal Circuit to review a panel decision finding that a forum selection clause in a mutual confidentiality agreement with Nippon Shinyaku Co. barred seven Patent...To view the full article, register now.
Already a subscriber? Click here to view full article